Ledger.Open graph →
SEC Form D · filed July 18, 2019

Cage Bio, Inc

Offering
$11.9M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN CARLOS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Nathan Baumeister · Westwood, MAExec · DirectorJay Tuli · Westwood, MADirectorTom Shen · Westwood, MAExecMartin K. Reed · Vancouver, British Columbia, CanadaExec · DirectorJohn W. Watson · Vancouver, British Columbia, CanadaDirectorElizabeth Greenwood · Santa Monica, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗